Skip to content

Evaluating a Digital Intervention for Overactive Bladder

Evaluating a Digital Intervention for Overactive Bladder: Protocol for a Single-arm, Multisite Pilot Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05170100
Enrollment
29
Registered
2021-12-27
Start date
2021-09-01
Completion date
2021-11-07
Last updated
2021-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Brief summary

Overactive Bladder is characterised by (I) Urgency: the sudden and compelling desire to pass urine with or without accidental leakage; (II) Frequency: the need to pass urine far more regularly than is considered normal; and (III) Nocturia: the need to pass urine several times during the night. This study aims to investigate the feasibility, acceptability and preliminary efficacy of a digital intervention (the NUIG OAB App) for overactive bladder. Furthermore, this study will help determine the most appropriate outcomes for use in the future definitive RCT and the effect size for future sample size calculations. Participants will complete an 8-week intervention designed to reduce the symptoms of OAB, delivered through the NUIG OAB App. Participants will be asked to complete online surveys at baseline, 4 weeks and 8 weeks and an in-app Bladder Diary at weeks 1 and 8. There will be no in-person contact with participants by the study team.

Interventions

BEHAVIORALNUIG OAB App

An interactive software-delivered 8-week intervention accessed through the patients' mobile device. It provides best-practice behavioural therapy, and delivers evidence-based dietetics, physiotherapy and psychology treatments to reduce the symptoms of overactive bladder.

Sponsors

Enterprise Ireland
CollaboratorOTHER_GOV
National University of Ireland, Galway, Ireland
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. On waiting list for Urogynaecologist at participating hospital 2. Referred for Overactive bladder from GP 3. Symptoms of Overactive bladder to include at least one of the following: urgency of urination, frequency of urination or urge incontinence. 4. Female 5. 18 years or older 6. Own a smartphone

Exclusion criteria

1. Active/Recurrent urinary tract infection 2. Urinary retention 3. Bladder Pain Syndrome/ interstitial cystitis 4. Pelvic/gynae cancer 5. Pregnant 6. Dementia 7. Kidney problems 8. Stroke 9. Have/had a neuro-stimulation implant for treatment of OAB

Design outcomes

Primary

MeasureTime frameDescription
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Quality of Life Module (ICIQ-OABqol)baseline and week 8Change from baseline patient-reported overactive bladder related quality of life at week 8. Minimum score 25, maximum score 160. Greater values indicating increased impact on quality of life
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB)baseline and week 8Change from baseline patient-reported overactive bladder symptoms at week 8. Minimum score 0, maximum score 16. Greater values indicate increased symptom severity.
Change in Digital Bladder Diary frequency of urinationbaseline & week 8Change from baseline frequency of urination at week 8. Frequency of urination measured in-app, in real-time as number of urinations per day logged by user for 3 days at baseline and 3 days in week 8.

Secondary

MeasureTime frameDescription
Programme adherencedata collected throughout the 8 week intervention.Total number of seconds spent on app from day 1 of week 1 to day 7 of week 8. Total number of times app accessed between day 1 of week 1 and day 7 of week 8. Total number of in-app 'challenges' completed throughout the 8 week intervention.
Mobile Applications Rating Scale, user version (MARSu)week 4User reported ratings of app quality based on Engagement, Functionality, Aesthetics, and Information. Minimum score 20, maximum score 100. Greater values indicate higher app quality.
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB)baseline and week 4Change from baseline patient-reported overactive bladder symptoms at week 4. Minimum score 0, maximum score 16. Greater values indicate increased symptom severity.
Patient Global impression of improvementweek 8One item questionnaire with Likert scale of 1 to 7. Greater values indicate disimproved condion.
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Quality of Life Module (ICIQ-OABqol)baseline and week 4Change from baseline patient-reported overactive bladder related quality of life at week 4. Minimum score 25, maximum score 160. Greater values indicate increased impact on quality of life.

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026